Skip to main content

Unable to load price data. Sorry.


Javelin Pharmaceuticals, Inc. (NYSEMKT:JAV.DL)

CAPS Rating: No stars

The Company is engaged in the research, development and commercialization of innovative treatments for the relief of moderate to severe pain.

Unable to load market data for this Ticker. Sorry.



This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform

All-Star Players

0 Outperform
0 Underperform

Wall Street

0 Outperform
0 Underperform

Top NYSEMKT:JAV.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

BigFatBEAR (28.28)
Submitted September 01, 2009

Bravo, Port, vanamonde, and zzlangerhanz are all green-thumbed, as is a guy who really knows his biotechs over on's an impressive pitch, and an impressive array of… More

cut2qr (< 20)
Submitted March 29, 2007

Three drugs for post operative pain relief in phase 3 trials due to report next 3mo with one Wall Street pro saying a "transforming event" is around the corner. Sound's good BUT- 1st candidate is an injectable NSAID (Dyloject) that has been availble… More



  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about JAV.DL.

No one has written a Pitch for JAV.DL stock yet. Tell us why you think JAV.DL will outperform or underperform against the market.


Find the members with the highest scoring picks in JAV.DL.

No players have picked JAV.DL yet. Tell us why you think JAV.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for JAV.DL.